December 21st 2023EP. 1: Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma
January 29th 2024EP. 2: ASH 2023: PERSEUS Trial Overview
Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.
January 29th 2024EP. 3: Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients
A medical expert navigates the treatment landscape for patients newly diagnosed with multiple myeloma.
January 29th 2024EP. 4: ASH 2023: Analyzing IsKia Trial
The IsKia trial findings presented at ASH 2023 are highlighted by Dr Fonseca.
January 29th 2024EP. 5: Examining Data from MonumenTAL-2 Study
The MonumenTAL-2 study is discussed by Rafael Fonesca, MD.
January 29th 2024EP. 6: Optimizing Bispecific Use in Multiple Myeloma Treatment
A key opinion leader explores the integration of bispecifics into MM therapy regimens.
January 29th 2024EP. 7: Navigating Impact of RRMM Treatment on Patient Quality of Life
Dr Fonesca highlights key factors in multiple myeloma treatment affecting patient quality of life.
January 29th 2024EP. 8: Key RRMM-Related Takeaways from ASH 2023
Dr Fonesca provides his final thoughts recapping data and findings presented at ASH 2023.
